Crystal Structure of Human Epidermal Kallikrein 7 (hK7) Synthesized Directly in its Native State in E. coli: Insights into the Atomic Basis of its Inhibition by LEKTI Domain 6 (LD6)

Journal of Molecular Biology

Volumn 377, Issue 5, 2008, Pages 1488-1497

  Fernández, Israel S ^a   Ständker, Ludger ^a,b   Mägert, Hans Jürgen ^c   Forssmann, Wolf Georg ^b   Giménez Gallego, Guillermo ^a   Romero, Antonio ^a  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c ANHALT UNIVERSITY OF APPLIED SCIENCES   (Germany)

Author keywords

human tissue kallikreins; inhibition kinetics; LEKTI domain 6; serine proteases; X ray crystal structure

Indexed keywords

KALLIKREIN; KALLIKREIN 7; PROTEIN LEKTI DOMAIN 6; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; BACULOVIRUS; BINDING SITE; CONTROLLED STUDY; CRYSTAL STRUCTURE; ESCHERICHIA COLI; MOLECULAR MODEL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN STRUCTURE; STRUCTURAL HOMOLOGY;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 40849112916     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2008.01.089     Document Type: Article

References (54)

1. Werb Z. ECM and cell surface proteolysis: regulating cellular ecology. Cell 91 (1997) 439-442
2. Liu Y., Fields R.D., Festoff B.W., and Nelson P.G. Proteolytic action of thrombin is required for electrical activity-dependent synapse reduction. Proc. Natl Acad. Sci. USA 91 (1994) 10300-10304
3. Schachter M. Kallikreins (kininogenases)-a group of serine proteases with bioregulatory actions. Pharmacol. Rev. 31 (1979) 1-17
4. Stennicke H.R., and Salvesen G.S. Caspases - controlling intracellular signals by protease zymogen activation. Biochim. Biophys. Acta 1477 (2000) 299-306
5. Puente X.S., Sanchez L.M., Overall C.M., and Lopez-Otin C. Human and mouse proteases: a comparative genomic approach. Nature Rev. Genet. 4 (2003) 544-558
6. Yousef G.M., and Diamandis E.P. The new human tissue kallikrein gene family: structure, function, and association to disease. Endocrinol. Rev. 22 (2001) 184-204
7. Egelrud T., Hofer P.A., and Lundstrom A. Proteolytic degradation of desmosomes in plantar stratum corneum leads to cell dissociation in vitro. Acta Derm. Venereol. 68 (1988) 93-97
8. Liu X.L., Wazer D.E., Watanabe K., and Band V. Identification of a novel serine protease-like gene, the expression of which is down-regulated during breast cancer progression. Cancer Res. 56 (1996) 3371-3379
9. Yousef G.M., Magklara A., Chang A., Jung K., Katsaros D., and Diamandis E.P. Cloning of a new member of the human kallikrein gene family, KLK14, which is down-regulated in different malignancies. Cancer Res. 61 (2001) 3425-3431
10. Borgono C.A., Michael I.P., and Diamandis E.P. Human tissue kallikreins: physiologic roles and applications in cancer. Mol. Cancer Res. 2 (2004) 257-280
11. Bhoola K.D., Figueroa C.D., and Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol. Rev. 44 (1992) 1-80
12. Lilja H. A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein. J. Clin. Invest. 76 (1985) 1899-1903
13. Borgono C.A., and Diamandis E.P. The emerging roles of human tissue kallikreins in cancer. Nature Rev. Cancer 4 (2004) 876-890
14. Hansson L., Stromqvist M., Backman A., Wallbrandt P., Carlstein A., and Egelrud T. Cloning, expression, and characterization of stratum corneum chymotryptic enzyme. A skin-specific human serine proteinase. J. Biol. Chem. 269 (1994) 19420-19426
15. Yousef G.M., Scorilas A., Magklara A., Soosaipillai A., and Diamandis E.P. The KLK7 (PRSS6) gene, encoding for the stratum corneum chymotryptic enzyme is a new member of the human kallikrein gene family-genomic characterization, mapping, tissue expression and hormonal regulation. Gene 254 (2000) 119-128
16. Borgono C.A., Michael I.P., Komatsu N., Jayakumar A., Kapadia R., Clayman G.L., et al. A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation. J. Biol. Chem. 282 (2007) 3640-3652
17. Caubet C., Jonca N., Brattsand M., Guerrin M., Bernard D., Schmidt R., et al. Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7. J. Invest. Dermatol. 122 (2004) 1235-1244
18. Ekholm E., and Egelrud T. Stratum corneum chymotryptic enzyme in psoriasis. Arch. Dermatol. Res. 291 (1999) 195-200
19. Tanimoto H., Underwood L.J., Shigemasa K., Yan M., Yan S., Clarke J., et al. The stratum corneum chymotryptic enzyme that mediates shedding and desquamation of skin cells is highly overexpressed in ovarian tumor cells. Cancer 86 (1999) 2074-2082
20. Johnson S.K., Ramani V.C., Hennings L., and Haun R.S. Kallikrein 7 enhances pancreatic cancer cell invasion by shedding E-cadherin. Cancer 109 (2007) 1811-1820
21. Egelrud T., Brattsand M., Kreutzmann P., Walden M., Vitzithum K., Marx U.C., et al. hK5 and hK7, two serine proteinases abundant in human skin, are inhibited by LEKTI domain 6. Br. J. Dermatol. 153 (2005) 1200-1203
22. Magert H.J., Standker L., Kreutzmann P., Zucht H.D., Reinecke M., Sommerhoff C.P., et al. LEKTI, a novel 15-domain type of human serine proteinase inhibitor. J. Biol. Chem. 274 (1999) 21499-21502
23. Chavanas S., Bodemer C., Rochat A., Hamel-Teillac D., Ali M., Irvine A.D., et al. Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nature Genet. 25 (2000) 1141-1142
24. Walley A.J., Chavanas S., Moffatt M.F., Esnouf R.M., Ubhi B., Lawrence R., et al. Gene polymorphism in Netherton and common atopic disease. Nature Genet. 29 (2001) 175-178
25. Schechter N.M., Choi E.J., Wang Z.M., Hanakawa Y., Stanley J.R., Kang Y., et al. Inhibition of human kallikreins 5 and 7 by the serine protease inhibitor lympho-epithelial Kazal-type inhibitor (LEKTI). Biol. Chem. 386 (2005) 1173-1184
26. Katz B.A., Liu B., Barnes M., and Springman E.B. Crystal structure of recombinant human tissue kallikrein at 2.0 Å resolution. Protein Sci. 7 (1998) 875-885
27. Debela M., Magdolen V., Grimminger V., Sommerhoff C., Messerschmidt A., Huber R., et al. Crystal structures of human tissue kallikrein 4: activity modulation by a specific zinc binding site. J. Mol. Biol. 362 (2006) 1094-1107
28. Bernett M.J., Blaber S.I., Scarisbrick I.A., Dhanarajan P., Thompson S.M., and Blaber M. Crystal structure and biochemical characterization of human kallikrein 6 reveals that a trypsin-like kallikrein is expressed in the central nervous system. J. Biol. Chem. 277 (2002) 24562-24570
29. Gomis-Ruth F.X., Bayes A., Sotiropoulou G., Pampalakis G., Tsetsenis T., Villegas V., et al. The structure of human prokallikrein 6 reveals a novel activation mechanism for the kallikrein family. J. Biol. Chem. 277 (2002) 27273-27281
30. Fernández I., Ständker L., Forssmann W., Giménez-Gallego G., and Romero A. Crystallization and preliminary crystallographic studies of human kallikrein 7, a serine protease of the multigene kallikrein family. Acta Crystallogr. F 63 (2007) 669-672
31. Debela M., Goettig P., Magdolen V., Huber R., Schechter N.M., and Bode W. Structural basis of the zinc inhibition of human tissue kallikrein 5. J. Mol. Biol. 373 (2007) 1017-1031
32. Debela M., Hess P., Magdolen V., Schechter N.M., Steiner T., Huber R., et al. Chymotryptic specificity determinants in the 1.0 A structure of the zinc-inhibited human tissue kallikrein 7. Proc. Natl Acad. Sci. USA 104 (2007) 16086-16091
33. Fernandez-Tornero C., Ramon A., Navarro M.L., Varela J., and Gimenez-Gallego G. Synthesis of proteins with disulfide bonds in E. coli using defined culture media. Biotechniques 32 (2002) 1238-1242
34. Andrade M.A., Chacón P., Merelo J.J., and Morán F. Evaluation of secondary structure of proteins from UV circular dichroism using an unsupervised learning neural network. Protein Eng. 6 (1993) 383-390
35. Skytt A., Stromqvist M., and Egelrud T. Primary substrate specificity of recombinant human stratum corneum chymotryptic enzyme. Biochem. Biophys. Res. Commun. 211 (1995) 586-589
36. Kreutzmann P., Schulz A., Standker L., Forssmann W.G., and Magert H.J. Recombinant production, purification and biochemical characterization of domain 6 of LEKTI: a temporary Kazal-type-related serine proteinase inhibitor. J Chromatogr. B 803 (2004) 75-81
37. Kishi T., Kato M., Shimizu T., Kato K., Matsumoto K., Yoshida S., et al. Crystal structure of neuropsin, a hippocampal protease involved in kindling epileptogenesis. J. Biol. Chem. 274 (1999) 4220-4224
38. Vagin A., and Teplyakov A. MOLREP: an automated program for molecular replacement. J. Appl. Crystallogr. 30 (1997) 1022-1025
39. McCoy A.J., Grosse-Kunstleve R.W., Storoni L.C., and Read R.J. Likelihood-enhanced fast translation functions. Acta Crystallogr. D 61 (2005) 458-464
40. Dasgupta S., Iyer G.H., Bryant S.H., Lawrence C.E., and Bell J.A. Extent and nature of contacts between protein molecules in crystal lattices and between subunits of protein oligomers. Proteins: Struct. Funct. Genet. 28 (1997) 494-514
41. Lesk A.M., and Fordham W.D. Conservation and variability in the structures of serine proteinases of the chymotrypsin family. J. Mol. Biol. 258 (1996) 501-537
42. Debela M., Magdolen V., Schechter N., Valachova M., Lottspeich F., Craik C.S., et al. Specificity profiling of seven human tissue kallikreins reveals individual subsite preferences. J. Biol. Chem. 281 (2006) 25678-25688
43. Lauber T., Schulz A., Schweimer K., Adermann K., and Marx U.C. Homologous proteins with different folds: the three-dimensional structures of domains 1 and 6 of the multiple Kazal-type inhibitor LEKTI. J. Mol. Biol. 328 (2003) 205-219
44. Whitmore L., and Wallace B.A. DICHROWEB, an online server for protein secondary structure analyses from circular dichroism spectroscopic data. Nucleic Acids Res. 32 (2004) W668-W673
45. Leslie A.G. The integration of macromolecular diffraction data. Acta Crystallogr. D 62 (2006) 48-57
46. Evans P. Scaling and assessment of data quality. Acta Crystallogr. D 62 (2006) 72-82
47. Murshudov G.N., Vagin A.A., and Dodson E.J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D 53 (1997) 240-255
48. Emsley P., and Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D 60 (2004) 2126-2132
49. Matthews B.W. Solvent content of protein crystals. J. Mol. Biol. 33 (1968) 491-497
50. Vagin A., and Teplyakov A. A translation-function approach for heavy-atom location in macromolecular crystallography. Acta Crystallogr. D 54 (1998) 400-402
51. Pettersen E.F., Goddard T.D., Huang C.C., Couch G.S., Greenblatt D.M., Meng E.C., and Ferrin T.E. UCSF Chimera-a visualization system for exploratory research and analysis. J. Comput. Chem. 25 (2004) 1605-1612
52. Baker N.A., Sept D., Joseph S., Holst M.J., and McCammon J.A. Electrostatics of nanosystems: application to microtubules and the ribosome. Proc. Natl Acad. Sci. USA 98 (2001) 10037-10041
53. Bolognesi M., Gatti G., Menagatti E., Guarneri M., Marquart M., Papamokos E., and Huber R. Three-dimensional structure of the complex between pancreatic secretory trypsin inhibitor (Kazal type) and trypsinogen at 1.8 Å resolution. Structure solution, crystallographic refinement and preliminary structural interpretation. J. Mol. Biol. 162 (1982) 839-868
54. Brunger A.T., Adams P.D., Clore G.M., DeLano W.L., Gros P., Grosse-Kunstleve R.W., et al. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. D 54 (1998) 905-921